StemCells Incorporated

Type: Company
Name: StemCells Incorporated
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Stem Cell Therapeutics Markets

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells have become effective tools in blood ... [Published MarketResearch.com - 4 hours ago]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

StemCells Starts Phase II Cervical Spinal Cord Injury Study - Analyst Blog

We remind investors that earlier in the year, the company had reported encouraging interim results from a phase I/II thoracic SCI study. StemCells intends to present final data from the phase I/II study in mid-2015.According to the press release issued ... [Published Nasdaq - Oct 09 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

BCLI Gets A Pat On The Back, OXGN At Work, MDGN Rises After Hours

BrainStorm Cell Therapeutics Inc. (BCLI: Quote) has secured FDA's Fast Track product designation for its core technology, NurOwn, which is currently being studied in a randomized, double-blind, placebo-controlled phase II clinical trial in amyotrophic ... [Published RTTNews.com - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 1 reports

Research Analysts’ New Coverage for October, 7th (AAPL, AFMD, BRKS, CFG, DLLLF, ETE, ETP, MDVN, NYLD, RWLK)

Research Analysts’ new coverage for Tuesday, October 7th:ING Group assumed coverage on shares of Apple (NASDAQ:AAPL)Leerink Swann assumed coverage on shares of Affimed Therapeutics BV (NASDAQ:AFMD)CRT Capital began coverage on shares of Brooks Automation ... [Published American Banking News - Forex - Oct 07 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 2 reports

StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury

First Study Assessing Efficacy of Neural Stem Cells for the Treatment of Cervical Spinal Cord InjuryNEWARK, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell based therapies ... [Published Virtual Strategy Magazine - Oct 07 2014]
First reported Sep 24 2014 - Updated Sep 25 2014 - 1 reports

McDonald’s Corporation (MCD) Stock: A Slump From A Perfect Storm

NYSE:MCD Related posts: There’s A Perfect Storm Brewing For The Global Economy [Dow Jones Industrial Average 2 Minute(INDEXDJX:.DJI)] Why Exxon Mobil Corporation (XOM) Just Might Be The Perfect Investment Top Turnaround Stock For 2014 [Hewlett-Packard ... [Published Nation's Restaurant News - Sep 24 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

StemCells Inc ShortTerm Noise Creates Another Buying Opportunity

By JMY Investments :I dialed into the StemCells, Inc's (NASDAQ: STEM ) quarterly conference call expecting to hear from a company on its heels from recent allegations of covering up shoddy manufacturing practices by a former employee who is suing the ... [Published BioPortfolio - Aug 15 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

California stem cell agency head takes stand on 'personal ethics'

The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ... [Published Greenspace - Jul 26 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 2 reports

California stem cell agency to review dealings with StemCells Inc.

California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ... [Published Greenspace - Jul 11 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 1 reports

Ex-president of California stem cell agency now on board of StemCells Inc.

StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ... [Published Tech Chronicles - Jul 08 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Why StemCells (STEM) Stock Hit Another One-Year High Today

NEW YORK (TheStreet) -- StemCells  surged to another 52-week high of $2.34 on Friday, as the company continued to rise on the strength of its positive interim results from a Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cell ... [Published The Street Latest - Jun 20 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Why StemCells (STEM) Hit a One-Year High Today

NEW YORK (TheStreet) -- StemCells  surged to a 52-week high of $2 on Thursday after the company reported positive interim results from a Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cell platform in dry age-related macular ... [Published The Street Latest - Jun 19 2014]

Quotes

...M Buck Distinguished Chair in Neurological Surgery at the University of Miami Miller School of Medicine and principle investigator for the center. "I have been involved in pioneering research efforts in applying cellular transplants to treat spinal cord injury patients for many years, and have closely followed the pre-clinical and clinical efforts of StemCells. We are excited to be the first site to open this important clinical trial. This is a time of promise and hope for victims of spinal cord injuries and, should this study be successful, it moves us one step closer to our ultimate goal of curing paralysis."
"FIG. 3 depicts data from a study in which the average amount of various proteins secreted into the medium was measured after four days of culture."
"We rate STEMCELLS INC (STEM) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally high debt management risk."

More Content

All (43) | News (19) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (1) | Press Releases (17)
sort by: Date | Relevance
Stem Cell Therapeutics Markets [Published MarketResearch.com - 4 hours ago]
StemCells Starts Phase II Cervical Spinal Cord ... [Published Nasdaq - Oct 09 2014]
BCLI Gets A Pat On The Back, OXGN At Work, MDGN... [Published RTTNews.com - Oct 08 2014]
Research Analysts’ New Coverage for October, 7t... [Published American Banking News - Forex - Oct 07 2014]
StemCells, Inc. Initiates Phase II Clinical Tri... [Published Virtual Strategy Magazine - Oct 07 2014]
StemCells Begins Phase II Study In Cervical Spi... [Published RTTNews.com - Oct 07 2014]
McDonald’s Corporation (MCD) Stock: A Slump Fro... [Published Nation's Restaurant News - Sep 24 2014]
Stem Cell Therapy Market Growing at 39.5% CAGR,... [Published Stock Nod - Sep 23 2014]
Patent Application Titled "Encapsulated Kidney ... [Published HispanicBusiness.com - Sep 17 2014]
Five Questions With: Dr. Lars Wahlberg [Published Providence Business News - Sep 17 2014]
StemCells, Inc. to Participate at the 16th Annu... [Published GlobeNewswire: Acquisitions News - Sep 04 2014]
StemCells Inc ShortTerm Noise Creates Another B... [Published BioPortfolio - Aug 15 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
Why StemCells (STEM) Stock Is Down Today [Published The Street Latest - Jul 15 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Ex-president of California stem cell agency now... [Published Tech Chronicles - Jul 08 2014]
StemCells, Inc. Appoints Dr. Alan Trounson to B... [Published GlobeNewswire: Advertising News - Jul 07 2014]
Agreements, NDA Submissions, FDA Approvals, Enr... [Published Financial Services - Jul 07 2014]
Why StemCells (STEM) Stock Is Gaining Today [Published The Street Latest - Jul 02 2014]
Biotechnology Equities Technical Notes -- Resea... [Published Financial Services - Jun 26 2014]
StemCells, Inc. President and CEO Martin McGlyn... [Published GlobeNewswire: Webcast News - Jun 23 2014]
Why StemCells (STEM) Stock Hit Another One-Year... [Published The Street Latest - Jun 20 2014]
StemCells, Inc. Announces Closure of Enrollment... [Published GlobeNewswire: Acquisitions News - Jun 20 2014]
5 Stocks Under $10 Set to Soar [Published The Street Latest - Jun 19 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ...
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this ...
Ex-president of California stem cell agency now... [Published Tech Chronicles - Jul 08 2014]
StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ...
1 2

Press Releases

sort by: Date | Relevance
StemCells, Inc. to Participate at the 16th Annu... [Published GlobeNewswire: Acquisitions News - Sep 04 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.